Formulation, Development and Invitro Evaluation of Nicorandil Extended Release Tablets

The nicorandil extended release tablets are prepared by wet granulation method using differentpolymers in varying combinations.. Compatability studies were carried out and found that drugs andexcipients are compatible with each other.post compression parameters were carried out found to bewithin the limits. Tablet blends were prepared and micromeritic studies were carried out are found to bewithin the limits. The dissolution data of all formulations reveals that as combination of Compritol,Carbopol showed increases the percentage drug release was found to be increased Formulation (F8)containing combination of Compritol, Carbopol934P shows that the 98.5% drug release was found in24hrs .

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-12-03
DOI
https://doi.org/10.5281/zenodo.14263233
Primary Topic
Drug Solubulity and Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Formulation, Development and Invitro Evaluation of Nicorandil Extended Release Tablets

Zenodo (CERN European Organization for Nuclear Research)
Drug Solubulity and Delivery Systems
article

Formulation, Development and Invitro Evaluation of Nicorandil Extended Release Tablets

article en

Abstract

The nicorandil extended release tablets are prepared by wet granulation method using differentpolymers in varying combinations.. Compatability studies were carried out and found that drugs andexcipients are compatible with each other.post compression parameters were carried out found to bewithin the limits. Tablet blends were prepared and micromeritic studies were carried out are found to bewithin the limits. The dissolution data of all formulations reveals that as combination of Compritol,Carbopol showed increases the percentage drug release was found to be increased Formulation (F8)containing combination of Compritol, Carbopol934P shows that the 98.5% drug release was found in24hrs .

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 70%
Drug Solubulity and Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Formulation, Development and Invitro Evaluation of Nicorandil Extended Release Tablets · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS